Rheumatoid Arthritis Clinical Trials

Showing 21-40 of 35,946 trials

Association Between LRG and Histologic Remission in Ulcerative Colitis

NCT06372613

We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.

Ulcerative Colitis in Histologic Remission

Showa Inan General Hospital100 participantsStarted Feb 2024

Komagane, Japan

Active Not RecruitingPhase 3

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.

Generalized Myasthenia Gravis

UCB Biopharma SRL200 participantsStarted Dec 2019

Mobile, Alabama, United States • Phoenix, Arizona, United States • Irvine, California, United States +67 more locations

Association Between LRG and Histologic Remission in Ulcerative Colitis

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Related Searches

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Natural History of Eye Diseases Related to ABCA4 Mutations

Using Generative AI to Enhance Clinical Prioritization and Cultural Competence of Students in Community Health Practice

The Effect of Art-Based Nursing Intervention Helping to Develop Healthy Digital Habits on Digital Addiction, Cyberbullying and Self-Efficacy in Adolescents

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Impacts of Clinician-Mediated Report-Back

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Effects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

The Effect of Cold Application in Patients With Rheumatoid Arthritis

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study